Publication | Closed Access

Prospective, Risk-Adapted Strategy of Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Trial

Adaptive RadiotherapyRadiation MedicinePhase Ii TrialRadiation TherapyMedicineRisk-adapted StrategyStereotactic Body RadiotherapyOncologyRadiation OncologyLung CancerRadiologyHealth Sciences